Jennison Associates’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-114,580	Closed	-$764K	–	627
2025 Q1	$764K	Buy	114,580 +44,276	+63%	+$437K	﹤0.01%	508
2024 Q4	$884K	Buy	70,304 +29,564	+73%	+$445K	﹤0.01%	501
2024 Q3	$752K	Buy	40,740 +10,162	+33%	+$208K	﹤0.01%	512
2024 Q2	$658K	Buy	30,578 +3,795	+14%	+$87.2K	﹤0.01%	527
2024 Q1	$722K	Buy	26,783 +903	+3%	+$25.6K	﹤0.01%	528
2023 Q4	$776K	Sell	25,880 -1,756	-6%	-$38.8K	﹤0.01%	521
2023 Q3	$566K	Sell	27,636 -6,043	-18%	-$110K	﹤0.01%	533
2023 Q2	$669K	Buy	+33,679	New	+$680K	﹤0.01%	530
2018 Q1	–	Sell	-341,713	Closed	-$3.57M	–	695
2017 Q4	$3.57M	Sell	341,713 -47,466	-12%	-$471K	﹤0.01%	507
2017 Q3	$2.77M	Buy	+389,179	New	+$1.78M	﹤0.01%	521
2017 Q1	–	Sell	-495,211	Closed	-$12.1M	–	771
2016 Q4	$12.1M	Buy	495,211 +1,173	+0.2%	+$33.5K	0.01%	465
2016 Q3	$18.7M	Buy	494,038 +6,941	+1%	+$218K	0.02%	424
2016 Q2	$14.5M	Sell	487,097 -388	-0.1%	-$13.6K	0.02%	438
2016 Q1	$14.4M	Buy	487,485 +7,522	+2%	+$226K	0.02%	437
2015 Q4	$21.8M	Buy	479,963 +5,257	+1%	+$229K	0.02%	415
2015 Q3	$17.8M	Buy	474,706 +106,092	+29%	+$4.87M	0.02%	449
2015 Q2	$7.22M	Buy	368,614 +118,384	+47%	+$2.62M	0.01%	529
2015 Q1	$5.42M	Buy	+250,230	New	+$5.87M	0.01%	515

Other funds holding RCKT